Arvind Kush
Chair of the BoardatInhibikase Therapeutics· In proxies 2024–2025
Arvind Kush sits on 1 public board.
Boards1
- Inhibikase TherapeuticsDirector · 0 yr on the boardIndependentAudit (Chair), Compensation—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Inhibikase TherapeuticsPublic company · 2 yr
- Chair of the Board2024 – Present · 2 yrStock in role +32%
Roles come from the proxy statements of each company.
Activity
Two people shown as one, or a wrong number?